Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
15/10/2026 16:37
BRIEF-Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit Oct 15 (Reuters) - Mankind Pharma Ltd MNKI.NS:
MANKIND PHARMA - TO BUY 70% MAJORITY STAKE IN ARMED CELL THERAPEUTICS THROUGH SUBSIDIARY
MANKIND PHARMA - APPROVES ADDITIONAL INVESTMENT IN UNIT, LIMIT NOW TO EUR 50 MILLION
MANKIND PHARMA - TO INVEST EUR 48 MILLION FOR 70% STAKE IN ARMED CELL THERAPEUTICS
Source text: ID:nBSE6n7V2S
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery